ROsuvastatin LOading and Clinical Outcomes Trial

Update Il y a 4 ans
Reference: NCT01936805

Woman and Man

  • | Country :
  • Turkey
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The aim of the present study was to evaluate the effect of pre-procedural single high loading dose (40 mg) of rosuvastatin on the primary end-points of all cause mortality and composite of death or myocardial infarction from cardiovascular (CV) causes, target vessel revascularization (TVR), or stroke.


Inclusion criteria

  • Atherosclerosis

Links